[Effect of ergot alkaloids on lipolysis and on glucagon-induced insulin secretion in normal and obese subjects]. 1977

S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
June 1975, The Tohoku journal of experimental medicine,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
January 1977, Pharmacology,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
October 1981, Acta endocrinologica,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
June 1978, Il Farmaco; edizione pratica,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
March 2009, American journal of physiology. Endocrinology and metabolism,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
April 1985, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
June 1969, Diabetologia,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
April 1968, Klinische Wochenschrift,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
January 1977, Acta diabetologica latina,
S Bertolini, and C Castello, and F Astengo, and M Risso, and P Fuliano, and A Fattorini, and R Balestreri
June 1973, Metabolism: clinical and experimental,
Copied contents to your clipboard!